HERANTIS PHARMA OYJ
502098-0412ActiveDeveloping disease-modifying therapies for Parkinson's disease progression.
Clinical-Stage Biotechnology Companyherantis.com
Översikt
- 0
- Anställda
- Okänt
- Omsättning
- 2025
- Grundat
Nyckelbeslutsfattare
Tone Kvåle
Chief Financial Officer
@herantis.com+47915XXXXX
Henri Huttunen
Chief Scientific Officer
@herantis.com
Timo Veromaa
Chairman of the Board
@herantis.com
Hilde Furberg
Board Member
@herantis.com
+4 fler kontakter i Funnelfeedr
Beskrivning
Herantis Pharma Plc is a clinical-stage biotechnology company dedicated to addressing the unmet medical need in neurodegenerative diseases. Their primary focus is developing disease-modifying therapies aimed at stopping or reversing disease progression, specifically targeting Parkinson's disease. Th...
Polku Therapeutics Oy